Working… Menu

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST (POETIG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03171389
Recruitment Status : Unknown
Verified May 2017 by Sebastian Bauer, Universität Duisburg-Essen.
Recruitment status was:  Recruiting
First Posted : May 31, 2017
Last Update Posted : May 31, 2017
Hannover Medical School
Helios Klinikum Berlin-Buch
University Hospital Tuebingen
Universitätsmedizin Mannheim
University Hospital, Aachen
Helios Klinikum Bad Saarow
Information provided by (Responsible Party):
Sebastian Bauer, Universität Duisburg-Essen

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 22, 2018
Estimated Study Completion Date : September 22, 2020